3Z-20-001

N/A

Report date: 2023/10/25 16:46:54
NME

Base Information

Drug Name3Z-20-001
Drug Alias Name3Z-20-001
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIceland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies3Z Pharmaceuticals
China Registration ClassN/A

Develop Information

Active Companies3Z Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A